Pitolisant oxalateNonimidazole inverse agonist CAS# 362665-57-4 |
2D Structure
- Lidocaine
Catalog No.:BCC1084
CAS No.:137-58-6
- Mianserin HCl
Catalog No.:BCC1114
CAS No.:21535-47-7
- Loratadine
Catalog No.:BCC1262
CAS No.:79794-75-5
- Bavisant
Catalog No.:BCC1402
CAS No.:929622-08-2
- Bavisant dihydrochloride
Catalog No.:BCC1403
CAS No.:929622-09-3
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 362665-57-4 | SDF | Download SDF |
PubChem ID | 23137286 | Appearance | Powder |
Formula | C19H28ClNO5 | M.Wt | 385.88 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 50 mg/mL (129.57 mM; Need ultrasonic) | ||
Chemical Name | 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine;oxalic acid | ||
SMILES | C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl.C(=O)(C(=O)O)O | ||
Standard InChIKey | OZTKSXOIWBLDBB-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C17H26ClNO.C2H2O4/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19;3-1(4)2(5)6/h7-10H,1-6,11-15H2;(H,3,4)(H,5,6) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Pitolisant oxalate Dilution Calculator
Pitolisant oxalate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.5915 mL | 12.9574 mL | 25.9148 mL | 51.8296 mL | 64.787 mL |
5 mM | 0.5183 mL | 2.5915 mL | 5.183 mL | 10.3659 mL | 12.9574 mL |
10 mM | 0.2591 mL | 1.2957 mL | 2.5915 mL | 5.183 mL | 6.4787 mL |
50 mM | 0.0518 mL | 0.2591 mL | 0.5183 mL | 1.0366 mL | 1.2957 mL |
100 mM | 0.0259 mL | 0.1296 mL | 0.2591 mL | 0.5183 mL | 0.6479 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Description: IC50 Value: 0.16 nM(Ki value); 1.5 nM(EC50) [1] Pitolisant (BF2.649) is a novel, potent, and selective nonimidazole inverse agonist at the recombinant human H3 receptor. BF2.649 behaved as a competitive antagonist with a Ki value of 0.16 nM and as an inverse agonist with an EC50 value of 1.5 nM and an intrinsic activity approximately 50% higher than that of ciproxifan. in vitro: BF2.649 behaved as a competitive antagonist with a Ki value of 0.16 nM and as an inverse agonist with an EC50 value of 1.5 nM and an intrinsic activity approximately 50% higher than that of ciproxifan. Pitolisant in vitro potency was approximately 6 times lower at the rodent receptor [1]. in vivo: In mice, the oral bioavailability coefficient, i.e., the ratio of plasma areas under the curve after oral and i.v. administrations, respectively, was 84%. BF2.649 dose dependently enhanced tele-methylhistamine levels in mouse brain, an index of histaminergic neuron activity, with an ED50 value of 1.6 mg/kg p.o., a response that persisted after repeated administrations for 17 days [1]. A statistically significant suppressive effect (standardized photosensitive response [SPR] reduction as measured with paired t-tests) for 20-, 40-, or 60-mg doses of pitolisant was seen in 9/14 (64%) patients of whom 6/14 (43%) showed abolition of the response to intermittent photic stimulation (IPS) [2]. BF2.649 showed significant inhibitory activity in several mouse models of schizophrenia [3]. Clinical trial: HARMONYIII: Long-term, Open-label Study in Narcolepsy With BF2.649 (Pitolisant). Phase3
- Pitolisant
Catalog No.:BCC1862
CAS No.:362665-56-3
- Clemaphenol A
Catalog No.:BCN7834
CAS No.:362606-60-8
- (±)-SLV 319
Catalog No.:BCC7954
CAS No.:362519-49-1
- TC 1
Catalog No.:BCC7450
CAS No.:362512-81-0
- Cyclo(D-Leu-L-Pro)
Catalog No.:BCN4028
CAS No.:36238-67-2
- Jatrorrhizine
Catalog No.:BCN5319
CAS No.:3621-38-3
- Columbamine
Catalog No.:BCN2722
CAS No.:3621-36-1
- NVP 231
Catalog No.:BCC4244
CAS No.:362003-83-6
- 2-Methoxyestradiol (2-MeOE2)
Catalog No.:BCC2228
CAS No.:362-07-2
- Genistein 7,4'-di-O-beta-D-glucopyranoside
Catalog No.:BCN7835
CAS No.:36190-98-4
- 3'-O-Methylorobol
Catalog No.:BCN5318
CAS No.:36190-95-1
- 3-Acetyl-2,5-dichlorothiophene
Catalog No.:BCC8602
CAS No.:36157-40-1
- Hederasaponin B
Catalog No.:BCN1085
CAS No.:36284-77-2
- Prostaglandin E2
Catalog No.:BCC7316
CAS No.:363-24-6
- Broussonol E
Catalog No.:BCN7996
CAS No.:363134-28-5
- Piroxicam
Catalog No.:BCC3841
CAS No.:36322-90-4
- YL-109
Catalog No.:BCC5543
CAS No.:36341-25-0
- Cyclo(L-Ala-L-Pro)
Catalog No.:BCN4012
CAS No.:36357-32-1
- Oxyphyllenone A
Catalog No.:BCN7103
CAS No.:363610-34-8
- 4-Methylhistamine dihydrochloride
Catalog No.:BCC7337
CAS No.:36376-47-3
- α,α'-Bis(4-hydroxy-3,5-dimethylphenyl)-1,4-diisopropylbenzene
Catalog No.:BCC9196
CAS No.:36395-57-0
- Metoclopramide
Catalog No.:BCC1743
CAS No.:364-62-5
- Diazoxide
Catalog No.:BCC6868
CAS No.:364-98-7
- A 419259
Catalog No.:BCC4307
CAS No.:364042-47-7